$BGM
Qilian International Holding Group Ltd Stock $bgm

$bgm Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 20-F Financial Statement

#000141057823000745 Filed on April 19, 2023

Income Statement

Concept	2022 Q3	2022	2021 Q3
Revenue	$32.77M	$64.86M	$27.16M
YoY Change	20.65%	13.58%	-45.71%
Cost Of Revenue	$29.36M	$58.63M	$25.61M
YoY Change	14.64%	13.93%	-39.73%
Gross Profit	$3.407M	$6.227M	$1.548M
YoY Change	120.11%	10.44%	-79.47%
Gross Profit Margin	10.4%	9.6%	5.7%
Selling, General & Admin	$2.532M	$4.125M	$1.432M
YoY Change	76.87%	27.23%	-46.46%
% of Gross Profit	74.33%	66.25%	92.5%
Research & Development		$1.224M
YoY Change		15204.3%
% of Gross Profit		19.66%
Depreciation & Amortization	$682.5K	$1.225M	$924.2K
YoY Change	-26.16%	1.95%	74.38%
% of Gross Profit	20.03%	19.67%	59.71%
Operating Expenses	$2.532M	$5.350M	$1.432M
YoY Change	76.86%	64.58%	-47.52%
Operating Profit	$874.8K	$2.102M	$116.1K
YoY Change	653.45%	-11.98%	-97.59%
Interest Expense	$151.5K	-$787.9K	$484.7K
YoY Change	-68.76%	-294.87%	-299.58%
% of Operating Profit	17.31%	-37.49%	417.51%
Other Income/Expense, Net	$164.5K	-$541.4K	$240.6K
YoY Change	-31.62%	-194.84%	-80.55%
Pretax Income	$1.191M	$1.561M	$841.4K
YoY Change	41.51%	-53.6%	-85.51%
Income Tax	$74.15K	$194.3K	-$21.38K
% Of Pretax Income	6.23%	12.45%	-2.54%
Net Earnings	$988.8K	$1.077M	$802.3K
YoY Change	23.25%	-65.85%	-84.16%
Net Earnings / Revenue	3.02%	1.66%	2.95%
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	$0.03	$0.03	$22.44K
COMMON SHARES
Basic Shares Outstanding	35.75M	35.75M
Diluted Shares Outstanding		35.75M

Balance Sheet

Concept	2022 Q3	2022	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.32M	$14.32M	$10.47M
YoY Change	36.8%	36.8%	-11.82%
Cash & Equivalents	$14.32M		$10.47M
Short-Term Investments
Other Short-Term Assets	$1.559M	$1.964M	$3.947M
YoY Change	-60.49%	-50.07%	286.92%
Inventory	$8.879M	$8.879M	$12.50M
Prepaid Expenses	$88.73K		$84.43K
Receivables	$815.3K	$815.3K	$1.733M
Other Receivables	$1.470M	$4.056M	$11.72M
Total Short-Term Assets	$30.03M	$30.03M	$40.37M
YoY Change	-25.59%	-25.59%	7.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.18M	$10.27M	$9.238M
YoY Change	10.24%	11.18%	20.6%
Goodwill
YoY Change
Intangibles	$1.727M		$1.928M
YoY Change	-10.43%
Long-Term Investments	$617.6K	$20.09M	$20.96M
YoY Change	-97.05%	-4.17%	3782.01%
Other Assets	$2.407M	$2.407M	$2.860M
YoY Change	-15.82%	-15.82%	429.57%
Total Long-Term Assets	$34.49M	$34.49M	$34.99M
YoY Change	-1.42%	-1.42%	229.45%
TOTAL ASSETS
Total Short-Term Assets	$30.03M	$30.03M	$40.37M
Total Long-Term Assets	$34.49M	$34.49M	$34.99M
Total Assets	$64.53M	$64.53M	$75.35M
YoY Change	-14.37%	-14.37%	56.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.289M	$5.991M	$6.644M
YoY Change	-20.38%	-9.83%	51.68%
Accrued Expenses	$23.86K	$23.86K	$55.85K
YoY Change	-57.28%	-57.28%	-30.19%
Deferred Revenue	$556.4K		$2.467M
YoY Change	-77.45%
Short-Term Debt	$1.672M	$1.672M	$7.867M
YoY Change	-78.74%	-78.74%	7.03%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.181M	$9.181M	$18.17M
YoY Change	-49.49%	-49.49%	-1.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$382.5K	$382.5K	$509.9K
YoY Change	-24.99%	-24.99%	-42.05%
Total Long-Term Liabilities	$382.5K	$382.5K	$509.9K
YoY Change	-24.99%	-24.99%	-42.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.181M	$9.181M	$18.17M
Total Long-Term Liabilities	$382.5K	$382.5K	$509.9K
Total Liabilities	$9.563M	$11.47M	$20.49M
YoY Change	-53.34%	-44.01%	-7.01%
SHAREHOLDERS EQUITY
Retained Earnings	$15.51M		$14.69M
YoY Change	5.55%
Common Stock	$59.58K		$59.58K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.05M	$53.05M	$54.86M
YoY Change
Total Liabilities & Shareholders Equity	$64.53M	$64.53M	$75.35M
YoY Change	-14.37%	-14.37%	56.53%

Cashflow Statement

Concept	2022 Q3	2022	2021 Q3
OPERATING ACTIVITIES
Net Income	$988.8K	$1.077M	$802.3K
YoY Change	23.25%	-65.85%	-84.16%
Depreciation, Depletion And Amortization	$682.5K	$1.225M	$924.2K
YoY Change	-26.16%	1.95%	74.38%
Cash From Operating Activities	$8.467M	$12.65M	$5.025M
YoY Change	68.5%	3567.56%	-2492.87%
INVESTING ACTIVITIES
Capital Expenditures	-$296.3K	$3.232M	-$2.273M
YoY Change	-86.97%	-192.53%	847.24%
Acquisitions
YoY Change
Other Investing Activities	-$116.9K	$0.00	-$20.37M
YoY Change	-99.43%	-100.0%	-101943.3%
Cash From Investing Activities	$179.4K	-$3.259M	-$22.64M
YoY Change	-100.79%	-86.53%	10680.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$23.92M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.077M	-5.938M	21.69M
YoY Change	-141.84%	-124.75%
NET CHANGE
Cash From Operating Activities	8.467M	12.65M	5.025M
Cash From Investing Activities	179.4K	-3.259M	-22.64M
Cash From Financing Activities	-9.077M	-5.938M	21.69M
Net Change In Cash	-430.2K	2.372M	4.078M
YoY Change	-110.55%	1614.36%	-1071.03%
FREE CASH FLOW
Cash From Operating Activities	$8.467M	$12.65M	$5.025M
Capital Expenditures	-$296.3K	$3.232M	-$2.273M
Free Cash Flow	$8.763M	$9.422M	$7.298M
YoY Change	20.07%	145.46%	24228.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001779578
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35750000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34089286
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30000000
CY2022Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.1135
CY2021Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.4580
CY2020Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8033
CY2022Q3	qli	Foreign Currency Exchange Average Rate ForeignCurrencyExchangeAverageRate	6.5532
CY2021Q3	qli	Foreign Currency Exchange Average Rate ForeignCurrencyExchangeAverageRate	6.5095
CY2020Q3	qli	Foreign Currency Exchange Average Rate ForeignCurrencyExchangeAverageRate	7.0077
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1559174
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2019Q4	us-gaap	Lease Practical Expedients Package LeasePracticalExpedientsPackage	true
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35750000
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35750000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39805
CY2022	dei	Entity Registrant Name EntityRegistrantName	Qilian International Holding Group Limited
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Jiuquan Economic and Technological Development Zone
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Jiuquan City
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	735000
CY2022	dei	Entity Address Country EntityAddressCountry	CN
CY2022	dei	Security12b Title Security12bTitle	Ordinary Shares
CY2022	dei	Trading Symbol TradingSymbol	QLI
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35750000
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	6413
CY2022	dei	Auditor Name AuditorName	ZH CPA, LLC
CY2022	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14319234
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10467357
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	659779
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	2140016
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	815325
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1733306
CY2022Q3	qli	Bank Acceptance Notes Receivable BankAcceptanceNotesReceivable	2585886
CY2021Q3	qli	Bank Acceptance Notes Receivable BankAcceptanceNotesReceivable	11722096
CY2022Q3	us-gaap	Inventory Net InventoryNet	8879486
CY2021Q3	us-gaap	Inventory Net InventoryNet	12495831
CY2022Q3	us-gaap	Supplies Supplies	1215105
CY2021Q3	us-gaap	Supplies Supplies	1380925
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1559174
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	425622
CY2022Q3	us-gaap	Assets Current AssetsCurrent	30033989
CY2021Q3	us-gaap	Assets Current AssetsCurrent	40365153
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10184029
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9119502
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1726928
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1927933
CY2022Q3	qli	Investment In Available For Sale Securities InvestmentInAvailableForSaleSecurities	19470400
CY2021Q3	qli	Investment In Available For Sale Securities InvestmentInAvailableForSaleSecurities	20323400
CY2022Q3	us-gaap	Long Term Investments LongTermInvestments	617570
CY2021Q3	us-gaap	Long Term Investments LongTermInvestments	639466
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86584
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118154
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	212876
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	427120
CY2022Q3	qli	Prepayments For Property And Equipment PrepaymentsForPropertyAndEquipment	2021330
CY2021Q3	qli	Prepayments For Property And Equipment PrepaymentsForPropertyAndEquipment	2243622
CY2022Q3	qli	Other Long Term Assets Noncurrent OtherLongTermAssetsNoncurrent	172911
CY2021Q3	qli	Other Long Term Assets Noncurrent OtherLongTermAssetsNoncurrent	188913
CY2022Q3	us-gaap	Assets Assets	64526617
CY2021Q3	us-gaap	Assets Assets	75353263
CY2022Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	140578
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5289481
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6643691
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	556418
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2467296
CY2022Q3	qli	Contract With Customer Liability Related Parties Current ContractWithCustomerLiabilityRelatedPartiesCurrent	0
CY2021Q3	qli	Contract With Customer Liability Related Parties Current ContractWithCustomerLiabilityRelatedPartiesCurrent	17318
CY2022Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1531649
CY2021Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	7867018
CY2022Q3	qli	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	121542
CY2021Q3	qli	Deferred Government Grants Current DeferredGovernmentGrantsCurrent	351567
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	815811
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	305305
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23859
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	55847
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	701263
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	466838
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9180601
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	18174880
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72537
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	106180
CY2022Q3	qli	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	309943
CY2021Q3	qli	Deferred Government Grants Non Current DeferredGovernmentGrantsNonCurrent	403745
CY2022Q3	us-gaap	Liabilities Liabilities	9563081
CY2021Q3	us-gaap	Liabilities Liabilities	18684805
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00166667
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00166667
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35750000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35750000
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	59583
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	59583
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36410931
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36390931
CY2022Q3	qli	Statutory Reserve StatutoryReserve	3118542
CY2021Q3	qli	Statutory Reserve StatutoryReserve	2857121
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15509177
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14693905
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2046091
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	857066
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	53052142
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	54858606
CY2022Q3	us-gaap	Minority Interest MinorityInterest	1911394
CY2021Q3	us-gaap	Minority Interest MinorityInterest	1809852
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54963536
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	56668458
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64526617
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75353263
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64855025
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57099884
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50033200
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	58627728
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	51461354
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	42494047
CY2022	us-gaap	Gross Profit GrossProfit	6227297
CY2021	us-gaap	Gross Profit GrossProfit	5638530
CY2020	us-gaap	Gross Profit GrossProfit	7539153
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4125294
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3250485
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2728009
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2102003
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2388045
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	4811144
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	24860
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-57671
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-242877
CY2022	qli	Investment Income InvestmentIncome	-812804
CY2021	qli	Investment Income InvestmentIncome	462014
CY2020	qli	Investment Income InvestmentIncome	57984
CY2022	qli	Grant Income GrantIncome	413717
CY2021	qli	Grant Income GrantIncome	564098
CY2020	qli	Grant Income GrantIncome	1082053
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-167217
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6791
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	97045
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-541444
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	975232
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	994205
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1560559
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3363277
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5805349
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	194302
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	255133
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	864908
CY2022	us-gaap	Profit Loss ProfitLoss	1366257
CY2021	us-gaap	Profit Loss ProfitLoss	3108144
CY2020	us-gaap	Profit Loss ProfitLoss	4940441
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	289564
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-44724
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-123269
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1076693
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3152868
CY2020	us-gaap	Net Income Loss NetIncomeLoss	5063710
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3091179
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1560381
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1263140
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1724922
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4668525
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	6203581
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	101542
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	56590
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1303
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1826464
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4611935
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6204884
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35750000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34089286
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30000000
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28841507
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23865085
CY2021	us-gaap	Profit Loss ProfitLoss	3108144
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	706659
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1560381
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	56668458
CY2022	us-gaap	Profit Loss ProfitLoss	1366257
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	20000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3091179
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54963536
CY2022	us-gaap	Profit Loss ProfitLoss	1366257
CY2021	us-gaap	Profit Loss ProfitLoss	3108144
CY2020	us-gaap	Profit Loss ProfitLoss	4940441
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	22451
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	62410
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	62410
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	20000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1224672
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1201229
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1105588
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-186814
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7918
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	188095
CY2022	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	444894
CY2021	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	92059
CY2020	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	-290968
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	189838
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-46187
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-86495
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-853000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	323400
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	40196
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	69494
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	57984
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8755
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1027671
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	545175
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	660667
CY2022	qli	Increase Decrease In Bank Acceptance Notes Receivable IncreaseDecreaseInBankAcceptanceNotesReceivable	-8744826
CY2021	qli	Increase Decrease In Bank Acceptance Notes Receivable IncreaseDecreaseInBankAcceptanceNotesReceivable	-387673
CY2020	qli	Increase Decrease In Bank Acceptance Notes Receivable IncreaseDecreaseInBankAcceptanceNotesReceivable	5583925
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2230723
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-46801
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1402620
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-41869
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	855977
CY2020	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-498378
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1198646
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1020875
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-125261
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-805443
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2015833
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	613339
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1827461
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1221897
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1461407
CY2022	qli	Increase Decrease In Contract With Customer Liability Related Parties IncreaseDecreaseInContractWithCustomerLiabilityRelatedParties	-17066
CY2021	qli	Increase Decrease In Contract With Customer Liability Related Parties IncreaseDecreaseInContractWithCustomerLiabilityRelatedParties	-17467
CY2020	qli	Increase Decrease In Contract With Customer Liability Related Parties IncreaseDecreaseInContractWithCustomerLiabilityRelatedParties	29973
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-275963
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-407563
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-314238
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	584693
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1142721
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	988423
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	301165
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-897496
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	722284
CY2022	qli	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-55036
CY2021	qli	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-12945
CY2020	qli	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-67928
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12654188
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	345034
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5076014
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3232269
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3491564
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	449766
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	26683
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1810
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	8798
CY2020	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-82972
CY2021	qli	Payments Purchase To Acquire Marketable Securities PaymentsPurchaseToAcquireMarketableSecurities	20000000
CY2021	qli	Acquisition Of Non Controlling Interest AcquisitionOfNonControllingInterest	706658
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3258953
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24200032
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-375592
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	3204541
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	7135009
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3051944
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	7681081
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	4994506
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-6090126
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	7804778
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	23869641
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5937529
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23993338
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2140503
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1086067
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	601903
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	431765
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2371640
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	740243
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7272690
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12607373
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11867130
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4594440
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14979013
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12607373
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11867130
CY2022	us-gaap	Interest Paid Net InterestPaidNet	122237
CY2021	us-gaap	Interest Paid Net InterestPaidNet	152499
CY2020	us-gaap	Interest Paid Net InterestPaidNet	280169
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	820972
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	275607
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	143443
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company, its subsidiaries, the VIE and VIE’s subsidiaries’ accounting estimates included, but are not limited to: allowance for estimated uncollectible receivables, inventory valuations, impairment of long-lived assets, impairment of intangible assets, and income taxes. Actual results could differ from those estimates.</p>
CY2022Q3	qli	Cash And Cash Equivalents Subject To Exchange Rate Risks CashAndCashEquivalentsSubjectToExchangeRateRisks	10277243
CY2022Q3	qli	Cash And Cash Equivalents Subject To Exchange Rate Risks CashAndCashEquivalentsSubjectToExchangeRateRisks	73107168
CY2021Q3	qli	Cash And Cash Equivalents Subject To Exchange Rate Risks CashAndCashEquivalentsSubjectToExchangeRateRisks	7305799
CY2021Q3	qli	Cash And Cash Equivalents Subject To Exchange Rate Risks CashAndCashEquivalentsSubjectToExchangeRateRisks	51226986
CY2022	qli	Number Of Units In Fund NumberOfUnitsInFund	20000
CY2022	qli	Net Asset Value Of Fund NetAssetValueOfFund	19470400
CY2021	qli	Net Asset Value Of Fund NetAssetValueOfFund	20323400
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	qli	Underwriter Warrants Diluted Earnings Per Share Calculation Using Treasury Stock Method UnderwriterWarrantsDilutedEarningsPerShareCalculationUsingTreasuryStockMethod	300000
CY2022Q3	us-gaap	Minority Interest MinorityInterest	1911394
CY2021Q3	us-gaap	Minority Interest MinorityInterest	1809852
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0
CY2022	qli	Government Grants GovernmentGrants	76299
CY2021	qli	Government Grants GovernmentGrants	152265
CY2020	qli	Government Grants GovernmentGrants	764962
CY2022	qli	Government Grants Income Recognized GovernmentGrantsIncomeRecognized	352262
CY2021	qli	Government Grants Income Recognized GovernmentGrantsIncomeRecognized	559828
CY2020	qli	Government Grants Income Recognized GovernmentGrantsIncomeRecognized	1079200
CY2022Q3	qli	Deferred Government Grants DeferredGovernmentGrants	431485
CY2021Q3	qli	Deferred Government Grants DeferredGovernmentGrants	755312
CY2022	qli	Governments Grants Weighted Average Remaining Period GovernmentsGrantsWeightedAverageRemainingPeriod	P3Y11M15D
CY2021	qli	Governments Grants Weighted Average Remaining Period GovernmentsGrantsWeightedAverageRemainingPeriod	P4Y1M24D
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1224344
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	166064
CY2021	us-gaap	Advertising Expense AdvertisingExpense	118020
CY2020	us-gaap	Advertising Expense AdvertisingExpense	2488
CY2021	qli	Underwriter Warrants Diluted Earnings Per Share Calculation Using Treasury Stock Method UnderwriterWarrantsDilutedEarningsPerShareCalculationUsingTreasuryStockMethod	300000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1076693
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3152868
CY2020	us-gaap	Net Income Loss NetIncomeLoss	5063710
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	35750000
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34089286
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	30000000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35750000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34089286
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30000000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	57099884
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	51461354
CY2021	us-gaap	Gross Profit GrossProfit	5638530
CY2021	qli	Depreciation And Amortization Excluding Amortization Of Right Of Use Assets DepreciationAndAmortizationExcludingAmortizationOfRightOfUseAssets	1201229
CY2021	qli	Capital Expenditures CapitalExpenditures	3493374
CY2022	qli	Fair Value Recurring Basis Assets And Liability Transfers Between Level1 And Level2 Net FairValueRecurringBasisAssetsAndLiabilityTransfersBetweenLevel1AndLevel2Net	0
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	20323400
CY2020Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	0
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	-853000
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Purchases FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPurchases	20000000
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	0
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	323400
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	19470400
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	20323400
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations and Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A majority of the Company, its subsidiaries, the VIE and VIE’s subsidiaries’ expense transactions are denominated in RMB and a significant portion of the Company and its subsidiaries, the VIE and VIE’s subsidiaries’ assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In the PRC, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange rates set by the People’s Bank of China (“PBOC”). Remittances in currencies other than RMB by the Company, its subsidiaries, the VIE and VIE’s subsidiaries in China must be processed through the PBOC or other China foreign exchange regulatory bodies which require certain supporting documentation in order to affect the remittance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of September 30, 2022 and 2021, $10,277,243 and $7,305,799 of the Company’s cash and cash equivalents, certificates of deposit and restricted cash were on deposit at financial institutions in the PRC where there currently is no rule or regulation requiring such financial institutions to maintain insurance to cover bank deposits in the event of bank failure. Cash and cash equivalent of $1,001,568 and $1,073,196 were deposited at financial institutions in Hong Kong as of September 30, 2022 and 2021, which are insured by Hong Kong Deposit Board and subject to a certain limitation of HKD 500,000 (approximately $ 65,000). As of September 30, 2022 and 2021, $3,700,202 and $4,228,173 of the Company’s cash were on deposit at financial institutions in the U.S. which were insured by the FDIC subject to certain limitations. The Company has not experienced any losses in such accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Substantially all of the Company’s sales are made to customers that are located in China. The Company has a concentration of its revenues and receivables with specific customers. For the year ended September 30, 2022, two customers accounted for 11% and 11% of total revenue, respectively and one vendor accounted for 14% of total purchase. As of September 30, 2022, three major customer’s account receivable accounted for 61%, 13% and 11% of the total account receivable, respectively, and one vendor accounted for 18% of the total accounts payable outstanding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has a concentration of its revenues and receivables with specific customers. For the year ended September 30, 2021, three customers accounted for 11%, 11% and 10% of total revenue, respectively and one vendor accounted for 13% of total purchase, respectively. As of September 30, 2021, one major customer’s account receivable accounted for 77% of the total account receivable, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the year ended September 30, 2020, three customers accounted for 18%, 11% and 10% of the Company’s total revenue, respectively and two vendors accounted for 11% and 10% of the Company’s total purchase, respectively As of September 30, 2020, three major customers’ account receivable accounted for 35%, 16% and 14% of the total account receivable, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A loss of any of these customers or suppliers could adversely affect the operating results or cash flows of the Company.</p>
CY2022Q3	qli	Cash And Cash Equivalents Uninsured Amount CashAndCashEquivalentsUninsuredAmount	10277243
CY2021Q3	qli	Cash And Cash Equivalents Uninsured Amount CashAndCashEquivalentsUninsuredAmount	7305799
CY2022Q3	qli	Cash And Cash Equivalents Deposited In Financial Institutions CashAndCashEquivalentsDepositedInFinancialInstitutions	1001568
CY2021Q3	qli	Cash And Cash Equivalents Deposited In Financial Institutions CashAndCashEquivalentsDepositedInFinancialInstitutions	1073196
CY2022Q3	qli	Cash And Cash Equivalents Deposited In Financial Institutions Annual Limit CashAndCashEquivalentsDepositedInFinancialInstitutionsAnnualLimit	500000
CY2022Q3	qli	Cash And Cash Equivalents Deposited In Financial Institutions Annual Limit CashAndCashEquivalentsDepositedInFinancialInstitutionsAnnualLimit	65000
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	3700202
CY2021Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	4228173
CY2021Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	113297
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	819698
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1945719
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4373
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	212413
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	815325
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1733306
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	4575964
CY2021Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	6285887
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	748845
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	832499
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4078142
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5502591
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	523465
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	125146
CY2022Q3	us-gaap	Inventory Net InventoryNet	8879486
CY2021Q3	us-gaap	Inventory Net InventoryNet	12495831
CY2021Q3	us-gaap	Deposit Assets DepositAssets	327104
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	88727
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	84428
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1470448
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	14090
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	425622
CY2022Q3	qli	Property Plant And Equipment Excluding Construction In Progress Gross PropertyPlantAndEquipmentExcludingConstructionInProgressGross	30902239
CY2021Q3	qli	Property Plant And Equipment Excluding Construction In Progress Gross PropertyPlantAndEquipmentExcludingConstructionInProgressGross	30144798
CY2022Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1198759
CY2021Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2020457
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21916969
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23045753
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10184029
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9119502
CY2022	us-gaap	Depreciation Depreciation	1172644
CY2021	us-gaap	Depreciation Depreciation	1145447
CY2020	us-gaap	Depreciation Depreciation	1055314
CY2022Q3	qli	Prepayments For Property And Equipment PrepaymentsForPropertyAndEquipment	2021330
CY2021Q3	qli	Property And Equipment Received Against Prepayments PropertyAndEquipmentReceivedAgainstPrepayments	2243622
CY2022Q3	qli	Property And Equipment Received Against Prepayments PropertyAndEquipmentReceivedAgainstPrepayments	2243622
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2409924
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2627460
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	682996
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	699527
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1726928
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1927933
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52028
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	55782
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50274
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	52668
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	52668
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	52668
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	52668
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	52668
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1463587
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1726928
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	212876
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	427120
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50033200
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	42494047
CY2020	us-gaap	Gross Profit GrossProfit	7539153
CY2022Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	463907
CY2021Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	510994
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	208255
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	188605
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	54592
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	60133
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	617570
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	639466
CY2022	qli	Investment Income Attributable To Equity Investment InvestmentIncomeAttributableToEquityInvestment	40196
CY2021	qli	Investment Income Attributable To Equity Investment InvestmentIncomeAttributableToEquityInvestment	69494
CY2020	qli	Investment Income Attributable To Equity Investment InvestmentIncomeAttributableToEquityInvestment	32093
CY2022Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	1531649
CY2021Q3	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	7867018
CY2022	qli	Repayment Of Notes Payable To Bank RepaymentOfNotesPayableToBank	1531649
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	659779
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	2140016
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64855025
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	58627728
CY2022	us-gaap	Gross Profit GrossProfit	6227297
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1560559
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	3363277
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	5805349
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4464
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	301320
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	951403
CY2022	qli	Deferred Income Tax Benefit Expense DeferredIncomeTaxBenefitExpense	189838
CY2021	qli	Deferred Income Tax Benefit Expense DeferredIncomeTaxBenefitExpense	-46187
CY2020	qli	Deferred Income Tax Benefit Expense DeferredIncomeTaxBenefitExpense	-86495
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	194302
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	255133
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	864908
CY2022	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	171217
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	458163
CY2020	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	603091
CY2022	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.006
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.013
CY2020	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.020
CY2022Q3	qli	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts And Inventory Provision DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndInventoryProvision	82111
CY2021Q3	qli	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts And Inventory Provision DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccountsAndInventoryProvision	51122
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	79588
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	262701
CY2022Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	51177
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.11
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.136
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.105
CY2022	qli	Effective Income Tax Rate Reconciliation Non Deductible Permanent Differences EffectiveIncomeTaxRateReconciliationNonDeductiblePermanentDifferences	-0.016
CY2021	qli	Effective Income Tax Rate Reconciliation Non Deductible Permanent Differences EffectiveIncomeTaxRateReconciliationNonDeductiblePermanentDifferences	-0.038
CY2020	qli	Effective Income Tax Rate Reconciliation Non Deductible Permanent Differences EffectiveIncomeTaxRateReconciliationNonDeductiblePermanentDifferences	0.004
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.125
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.076
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.149
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	556022
CY2021Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	64129
CY2022Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	142255
CY2021Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	148204
CY2022Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	117534
CY2021Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	92972
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	815811
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	305305
CY2022	qli	Number Of Operating Leases NumberOfOperatingLeases	1
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	63480
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	109346
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	71826
CY2022	qli	Depreciation And Amortization Excluding Amortization Of Right Of Use Assets DepreciationAndAmortizationExcludingAmortizationOfRightOfUseAssets	1224673
CY2022	qli	Capital Expenditures CapitalExpenditures	3232269
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86584
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118154
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86584
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118154
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23859
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	55847
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72537
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	106180
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	96396
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	162027
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y25D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28116
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	28116
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	28116
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	21087
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	105435
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9039
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	96396
CY2021Q1	qli	Warrant Term WarrantTerm	P5Y
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.50
CY2021Q1	qli	Percentage Of Warrants Exercise Price Based On Ipo Issue Price PercentageOfWarrantsExercisePriceBasedOnIpoIssuePrice	1.10
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	5.00
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	300000
CY2022	qli	Minimum Percentage Of Reserve Of Registered Capital For Statutory Surplus Reserve MinimumPercentageOfReserveOfRegisteredCapitalForStatutorySurplusReserve	0.10
CY2022Q3	qli	Percentage Of Statutory Surplus Reserve PercentageOfStatutorySurplusReserve	0.50
CY2022Q3	qli	Statutory Reserve StatutoryReserve	3118542
CY2021Q3	qli	Statutory Reserve StatutoryReserve	2857121
CY2020	qli	Depreciation And Amortization Excluding Amortization Of Right Of Use Assets DepreciationAndAmortizationExcludingAmortizationOfRightOfUseAssets	1105588
CY2020	qli	Capital Expenditures CapitalExpenditures	449765
CY2022Q3	us-gaap	Assets Assets	64526617
CY2021Q3	us-gaap	Assets Assets	75353263
CY2022Q3	qli	Commitments Amount Paid CommitmentsAmountPaid	2700000
CY2022Q3	qli	Commitments Amount Paid CommitmentsAmountPaid	18900000
CY2022Q3	us-gaap	Other Commitment OtherCommitment	1300000
CY2022Q3	us-gaap	Other Commitment OtherCommitment	9000000.0

Files In Submission

Name	View Source	Status
0001410578-23-000745-index-headers.html	Edgar Link	pending
0001410578-23-000745-index.html	Edgar Link	pending
0001410578-23-000745.txt	Edgar Link	pending
0001410578-23-000745-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmb-20220930.xsd	Edgar Link	pending
tmb-20220930x20f.htm	Edgar Link	pending
tmb-20220930x20f002.jpg	Edgar Link	pending
tmb-20220930x20f004.jpg	Edgar Link	pending
tmb-20220930x20f013.jpg	Edgar Link	pending
tmb-20220930x20f014.jpg	Edgar Link	pending
tmb-20220930xex12d1.htm	Edgar Link	pending
tmb-20220930xex12d2.htm	Edgar Link	pending
tmb-20220930xex13d1.htm	Edgar Link	pending
tmb-20220930xex13d2.htm	Edgar Link	pending
tmb-20220930xex15d1.htm	Edgar Link	pending
tmb-20220930xex2d2.htm	Edgar Link	pending
tmb-20220930xex8d1.htm	Edgar Link	pending
tmb-20220930_def.xml	Edgar Link	unprocessable
tmb-20220930_cal.xml	Edgar Link	unprocessable
tmb-20220930_lab.xml	Edgar Link	unprocessable
tmb-20220930_pre.xml	Edgar Link	unprocessable
tmb-20220930x20f_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGM
Qilian International Holding Group Ltd Stock $bgm

2022 Q3 Form 20-F Financial Statement

#000141057823000745 Filed on April 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGM Qilian International Holding Group Ltd Stock $bgm

2022 Q3 Form 20-F Financial Statement

#000141057823000745 Filed on April 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGM
Qilian International Holding Group Ltd Stock $bgm